These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38333526)
21. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J; Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608 [TBL] [Abstract][Full Text] [Related]
22. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E; Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034 [TBL] [Abstract][Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
25. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis. Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G; Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912 [TBL] [Abstract][Full Text] [Related]
26. Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative. Vidal C; Ruano C; Bernardino V; Lavado Carreira P; Lladó A; Santos MC; Gruner H; Panarra A; Riso N; Moraes-Fontes MF Acta Med Port; 2018 Jun; 31(6):312-320. PubMed ID: 30020876 [TBL] [Abstract][Full Text] [Related]
27. Marker antibodies in scleroderma and polymyositis: clinical associations. de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546 [TBL] [Abstract][Full Text] [Related]
28. Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience. Küçükşahin O; Yildizgören MT; Gerede DM; Maraş Y; Erten Ş Arch Rheumatol; 2016 Sep; 31(3):229-233. PubMed ID: 29900941 [TBL] [Abstract][Full Text] [Related]
29. Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Tieu A; Chaigne B; Dunogué B; Dion J; Régent A; Casadevall M; Cohen P; Legendre P; Terrier B; Costedoat-Chalumeau N; Le Jeunne C; Mouthon L Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626223 [TBL] [Abstract][Full Text] [Related]
30. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppression use in early systemic sclerosis may be increasing over time. Park R; Nevskaya T; Baron M; Pope JE J Scleroderma Relat Disord; 2022 Feb; 7(1):33-41. PubMed ID: 35386940 [TBL] [Abstract][Full Text] [Related]
32. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M; Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630 [TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort. Sandhya P; Jeyaseelan L; Scofield RH; Danda D Open Rheumatol J; 2015; 9():36-45. PubMed ID: 26161156 [TBL] [Abstract][Full Text] [Related]
34. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460 [TBL] [Abstract][Full Text] [Related]
35. Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registry. Freitas R; Martins P; Dourado E; Santiago T; Guimarães F; Fernandes BM; Garcia S; Samões B; Pinto AS; Gonçalves N; Lourenço MH; Costa E; Rocha M; Couto M; Duarte AC; Araújo F; Cordeiro I; Godinho F; Resende C; Salvador MJ; Cordeiro A; Santos MJ ARP Rheumatol; 2022; 1(1):21-29. PubMed ID: 35633574 [TBL] [Abstract][Full Text] [Related]